New Approaches to Predicting Diabetes Risk
Global Diabetes Prevalence
Recent studies indicate that approximately 1 in 9 adults worldwide is diagnosed with diabetes, with over 90% of these cases being type 2 diabetes.
Challenges in Diagnosing Type 2 Diabetes
Type 2 diabetes often presents diagnostic challenges. Symptoms may take years to develop or might not be evident at all, making early detection difficult. Dr. Jun Li, MD, PhD, an assistant professor of medicine and associate epidemiologist at Mass General Brigham, emphasized, “Type 2 diabetes develops slowly — by the time of diagnosis, adverse changes to the heart, kidneys, or blood vessels may have already begun.”
Limitations of Current Risk Evaluation Tools
Current methods for assessing diabetes risk primarily consider factors such as age, body weight, family history, and blood sugar levels. While these factors are useful, they do not adequately reflect the biological changes that lead to diabetes, resulting in many individuals not being identified as high risk until it is too late.
Innovative Research Directions
In light of these challenges, researchers are exploring new diagnostic methods. A recent study published in the journal *Nature* introduced an advanced artificial intelligence (AI) model that can more accurately identify individuals at high risk for both diabetes and cardiovascular disease mortality compared to the conventional HbA1c test, which assesses average blood sugar levels over a three-month period.
Significance of Blood Molecules in Risk Prediction
Additionally, Dr. Li is a co-author of another study published in *Nature Medicine*, which discovered small molecules in the blood that may offer insights into an individual’s future risk of developing type 2 diabetes, extending beyond traditional risk factors.
These advancements may pave the way for earlier and more effective diagnoses of type 2 diabetes, potentially improving patient outcomes.